Elizabeth Barrett - Jul 28, 2025 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role: Chief Executive Officer
Signature: /s/ Jason D. Smith, Attorney-in-Fact
Stock symbol: URGN
Transactions as of: Jul 28, 2025
Transactions value $: $0
Form type: 4
Date filed: 7/30/2025, 04:08 PM
Previous filing: Jun 23, 2025
Next filing: Jul 31, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Barrett Elizabeth A.	Chief Executive Officer	400 ALEXANDER PARK DRIVE, PRINCETON	/s/ Jason D. Smith, Attorney-in-Fact	2025-07-30	0001764157

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	URGN	Performance Stock Units	Award	$0	+87.6K		$0.00	87.6K	Jul 28, 2025	Ordinary Shares	87.6K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each performance stock unit represents a contingent right to receive one ordinary share of the Issuer.
F2	Represents performance stock units ("PSUs") granted to the reporting person on January 31, 2024 that were earned upon the achievement of a corporate milestone event. These PSUs remain subject to continued service through December 31, 2025, at which time they will vest and settle in ordinary shares.